Page 27 - Clinical Development News Today

In a significant development for the multiple myeloma community, Menarini Stemline UK today welcomed the final draft guidance from the National Institute for Health and Care Excellence (NICE).

Kynos Therapeutics Ltd, based in Edinburgh, UK, focuses on developing small molecule kynurenine 3-monooxygenase (KMO) inhibitors for inflammatory disorders.

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V. Explanatory Notes to the Agenda ProQR Therapeutics N.V. | Zernikedreef 9...

ASTRIA THERAPEUTICS, INC. 75 State Street, Suite 1400 Boston, MA 02109 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS ...

WALTHAM, Mass., April 22, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...

/PRNewswire/ -- DelveInsights Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment...

/PRNewswire/ -- Loyal, the San Francisco-based company dedicated to improving the health and longevity of dogs, and Prelude, the leading animal health-focused...

Earlier this week, Charles River Laboratories International, Inc. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.

Gifthealth began operations just under four years ago to provide a scalable solution for the cost and complexity of prescription drugs.

To make testing for colorectal cancer more bearable than biannunal colonoscopies, a test has been designed that is simple, effective, non-invasive and not unpleasant.